Verona Pharma (VRNA) Revenue & Revenue Breakdown
Verona Pharma Revenue Highlights
Latest Revenue (Y)
$42.28M
Latest Revenue (Q)
$76.26M
Main Segment (Y)
Product
Verona Pharma Revenue by Period
Verona Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $42.28M | 100.00% |
2023-12-31 | - | -100.00% |
2022-12-31 | $458.00K | -98.86% |
2021-12-31 | $40.00M | 100.00% |
2020-12-31 | - | -100.00% |
2019-12-31 | $2.35K | -15.52% |
2018-12-31 | $2.78K | -99.85% |
2017-12-31 | $1.84M | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2007-12-31 | - | 100.00% |
2006-12-31 | - | 100.00% |
2005-12-31 | - | - |
Verona Pharma generated $42.28M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 1798341.13% compared to the same period a year ago.
Verona Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2025-03-31 | $76.26M | 108.04% |
2024-12-31 | $36.66M | 551.76% |
2024-09-30 | $5.62M | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $940.06K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $458.00K | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2021-09-30 | $40.00M | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | -100.00% |
2019-12-31 | $2.35K | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | -100.00% |
2018-12-31 | $2.78K | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | -100.00% |
2017-12-31 | $1.84M | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2005-06-30 | - | - |
Verona Pharma generated $76.26M in revenue during Q1 2025, up 108.04% compared to the previous quarter, and up 8111.86% compared to the same period a year ago.
Verona Pharma Revenue Breakdown
Verona Pharma Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 24 |
---|---|
Product and Service, Other | $18.00K |
Product | $42.26M |
Latest
Verona Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (99.96%), and Product and Service, Other (0.04%).
Quarterly Revenue by Product
Product/Service | Mar 25 |
---|---|
Product and Service, Other | $5.00M |
Product | $71.26M |
Latest
Verona Pharma's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Product (93.44%), and Product and Service, Other (6.56%).
Verona Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
APLS | Apellis Pharmaceuticals | $709.95M | $212.53M |
MDGL | Madrigal Pharmaceuticals | $180.13M | $137.25M |
DAWN | Day One Biopharmaceuticals | $131.16M | $29.21M |
AMLX | Amylyx Pharmaceuticals | $87.37M | $-665.00K |
VRNA | Verona Pharma | $42.28M | $76.26M |
SNDX | Syndax Pharmaceuticals | $23.68M | $20.04M |
IDYA | IDEAYA Biosciences | $7.00M | $7.00M |
XFOR | X4 Pharmaceuticals | $2.56M | $28.81M |
AKRO | Akero Therapeutics | - | - |
PTGX | Protagonist Therapeutics | - | $170.64M |
VTYX | Ventyx Biosciences | - | - |
VKTX | Viking Therapeutics | - | - |
MLTX | MoonLake Immunotherapeutics | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |
MREO | Mereo BioPharma Group | - | - |